Cargando…

Immunotherapy Resistance in Glioblastoma

Glioblastoma is the most common malignant primary brain tumor in adults. Despite treatment consisting of surgical resection followed by radiotherapy and adjuvant chemotherapy, survival remains poor at a rate of 26.5% at 2 years. Recent successes in using immunotherapies to treat a number of solid an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Elaina J., Chen, Jia-Shu, Jain, Saket, Morshed, Ramin A., Haddad, Alexander F., Gill, Sabraj, Beniwal, Angad S., Aghi, Manish K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718605/ https://www.ncbi.nlm.nih.gov/pubmed/34976006 http://dx.doi.org/10.3389/fgene.2021.750675

Ejemplares similares

CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma
por: Safaee, Michael M., et al.
Publicado: (2022)

Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022)

ETMM-09 TARGETING GLIOBLASTOMA MULTIFORME METABOLISM AT THE INVASIVE TUMOR FRONT
por: Garcia, Joseph H, et al.
Publicado: (2021)

Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects
por: Jain, Saket, et al.
Publicado: (2023)

Metabolic Drivers of Invasion in Glioblastoma
por: Garcia, Joseph H., et al.
Publicado: (2021)

Sarcopenia Diagnosed Using Masseter Muscle Diameter as a Survival Correlate in Elderly Patients with Glioblastoma
por: Morshed, Ramin A., et al.
Publicado: (2022)

Metabolic Barriers to Glioblastoma Immunotherapy
por: Choudhary, Nikita, et al.
Publicado: (2023)

Recent advances in the molecular prognostication of meningiomas
por: Wang, Elaina J., et al.
Publicado: (2023)

Higher cytolytic score correlates with an immunosuppressive tumor microenvironment and reduced survival in glioblastoma
por: Haddad, Alexander F., et al.
Publicado: (2020)

Barriers to overcoming immunotherapy resistance in glioblastoma
por: Gillette, Julia S., et al.
Publicado: (2023)

Multi-omic screening of invasive GBM cells in engineered biomaterials and patient biopsies reveals targetable transsulfuration pathway alterations
por: Garcia, Joseph H., et al.
Publicado: (2023)

SURG-11. Surgery for control of brain metastases after prior checkpoint inhibitor immunotherapy: a single-center series
por: Morshed, Ramin, et al.
Publicado: (2021)

FLAIRectomy: Resecting beyond the Contrast Margin for Glioblastoma
por: Haddad, Alexander F., et al.
Publicado: (2022)

Mouse models of glioblastoma for the evaluation of novel therapeutic strategies
por: Haddad, Alexander F, et al.
Publicado: (2021)

OTEH-11. Single Cell RNA Sequencing to identify cellular heterogeneity with in Pituitary Adenomas
por: Jain, Saket, et al.
Publicado: (2021)

Anti-angiogenic therapies in the management of glioblastoma
por: Schulte, Jessica D., et al.
Publicado: (2021)

12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT
por: Morshed, Ramin, et al.
Publicado: (2020)

The Role of Cancer-Associated Fibroblasts in Tumor Progression
por: Joshi, Rushikesh S., et al.
Publicado: (2021)

Novel intraoperative strategies for enhancing tumor control: Future directions
por: Haddad, Alexander F, et al.
Publicado: (2022)

3352 Surgical Adjuvant of Immunomodulatory Gene Circuits for Treatment of Glioblastoma
por: Spatz, Jordan Matthew, et al.
Publicado: (2019)

Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker Candidates
por: Li, Qiang, et al.
Publicado: (2022)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
por: Zhang, Yu-Hang, et al.
Publicado: (2020)

Characterization of Chromosomal Instability in Glioblastoma
por: Balzano, Elisa, et al.
Publicado: (2022)

The immunogenetic impact of European colonization in the Americas
por: Collen, Evelyn Jane, et al.
Publicado: (2022)

Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

Apoptosis-Related Gene-Mediated Cell Death Pattern Induces Immunosuppression and Immunotherapy Resistance in Gastric Cancer
por: Yuan, Xiaolu, et al.
Publicado: (2022)

Systems Biology Approaches Toward Understanding Primary Mitochondrial Diseases
por: Maldonado, Elaina M., et al.
Publicado: (2019)

Comparative Transcriptome Analysis to Identify Candidate Genes for FaRCg1 Conferring Resistance Against Colletotrichum gloeosporioides in Cultivated Strawberry (Fragaria × ananassa)
por: Chandra, Saket, et al.
Publicado: (2021)

Identification of an Immune-Related Prognostic Risk Model in Glioblastoma
por: Lin, Zhiying, et al.
Publicado: (2022)

The potential of polymeric micelles in the context of glioblastoma therapy
por: Morshed, Ramin A., et al.
Publicado: (2013)

Ovarian Carcinosarcoma and Response to Immunotherapy
por: Daniyal, Muhammad, et al.
Publicado: (2023)

An Inflammatory Landscape for Preoperative Neurologic Deficits in Glioblastoma
por: Katrib, Amal, et al.
Publicado: (2019)

Immunogenomic Profiling Demonstrate AC003092.1 as an Immune-Related eRNA in Glioblastoma Multiforme
por: Guo, Xiao-Yu, et al.
Publicado: (2021)

Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma
por: Zhang, Yesen, et al.
Publicado: (2022)

Identification of BST2 Contributing to the Development of Glioblastoma Based on Bioinformatics Analysis
por: Kong, Yang, et al.
Publicado: (2022)

A Six-lncRNA Signature for Immunophenotype Prediction of Glioblastoma Multiforme
por: Gao, Ming, et al.
Publicado: (2021)

A pan-cancer analysis reveals the genetic alterations and immunotherapy of Piezo2 in human cancer
por: Liu, Xin, et al.
Publicado: (2022)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Network pharmacological analysis of active components of Xiaoliu decoction in the treatment of glioblastoma multiforme
por: Wu, Ji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0s2esndfnllfp57i502bedbp3r